Palvella Therapeutics Earnings
NASDAQ: PVLAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
138.77+7.43 (+5.66%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Palvella Therapeutics earnings summary
In its most recent report on Aug 4, 2026 (Q2 2026), PVLA posted EPS of $-1.52. Across the last 16 reports, PVLA shares moved an average of 7.8% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
PVLA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $-1.52 | — | -1.0% |
| May 7, 2026 | — | $-1.20 | — | -5.8% |
| Feb 24, 2026 | — | $-1.08 | — | -0.5% |
| Nov 10, 2025 | — | $-1.03 | — | +12.4% |
| Aug 14, 2025 | — | $-0.86 | — | +12.9% |
| May 15, 2025 | — | $-0.74 | — | +7.6% |
| Mar 31, 2025 | — | $0.12 | — | -9.3% |
| Nov 13, 2024 | — | $-3.94 | — | +5.7% |
| Aug 14, 2024 | — | $-2.47 | — | +8.7% |
| May 15, 2024 | — | $-1.54 | — | -4.5% |
| Mar 29, 2024 | — | $21.41 | — | -6.0% |
| Nov 14, 2023 | — | $-8.70 | — | -4.9% |
| Aug 10, 2023 | — | $3.62 | — | +19.4% |
| May 11, 2023 | — | $-14.15 | — | -4.8% |
| Mar 31, 2023 | — | $-0.11 | — | -20.1% |
| Nov 4, 2022 | — | $-0.13 | — | -2.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.